{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["23(1)"],"submitter":["Ramillon J"],"pubmed_abstract":["<h4>Background</h4>Taste or smell disorders have been reported as strongly associated with COVID-19 diagnosis. We aimed to identify subject characteristics, symptom associations, and antibody response intensity associated with taste or smell disorders.<h4>Methods</h4>We used data from SAPRIS, a study based on a consortium of five prospective cohorts gathering 279,478 participants in the French general population. In the analysis, we selected participants who were presumably infected by SARS-CoV-2 during the first epidemic wave.<h4>Results</h4>The analysis included 3,439 patients with a positive ELISA-Spike. Sex (OR = 1.28 [95% CI 1.05-1.58] for women), smoking (OR = 1.54 [95% CI 1.13-2.07]), consumption of more than 2 drinks of alcohol a day (OR = 1.37 [95% CI 1.06-1.76]) were associated w"],"journal":["BMC infectious diseases"],"pagination":["228"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10103027"],"repository":["biostudies-literature"],"pubmed_title":["Antibody response, associated symptoms and profile of patients presumably infected by SARS-CoV-2 with taste or smell disorders in the SAPRIS multicohort study."],"pmcid":["PMC10103027"],"pubmed_authors":["Ramillon J","Belhadji L","SAPRIS study group","Hoang L","Correia E","Amroun A","Dorival C","Zins M","de Lamballerie X","Hercberg S","Jusot F","Enguix M","Kab S","Morel V","Fourie T","Bajos N","Druesne-Pecollo N","Renuy A","Goldberg M","Gagliolo JM","Dufourg MN","Lusivika-Nzinga C","Benhammou V","Ouili O","Touvier M","Esseddik Y","Lydie N","Beaudoin JC","Blanche H","Deschasaux M","Gerbouin-Rerolle P","Pellicer M","Meyer L","Rouquette A","Thierry X","Deleuze JF","Seston M","Robineau O","Pailhe A","Esperou H","Allegre J","Ritmi A","Charles MA","Geay B","Lordmi E","Sebaoun JM","Artaud F","Goderel I","Milcent K","Severi G","Senina N","Lai C","Wiernik E","de Visme S","Pannetier G","Simeon T","Nicol J","Barry AA","Marchand L","Saba Villarroel PM","Rahib D","Priet S","SAPRIS-SERO study group","Spire A","Candea A","Lapidus N","Zaros C","Ninove L","Ancel PY","Szabo de Edelenyi F","Gomes-Rima R","Martin C","Couffin-Cadiergues S","Carrat F","Gressin L","Mohamed Ali S","Laplanche C","Ribet C","Ayhan N","Le-Got S","Pastorino B"],"additional_accession":[]},"is_claimable":false,"name":"Antibody response, associated symptoms and profile of patients presumably infected by SARS-CoV-2 with taste or smell disorders in the SAPRIS multicohort study.","description":"<h4>Background</h4>Taste or smell disorders have been reported as strongly associated with COVID-19 diagnosis. We aimed to identify subject characteristics, symptom associations, and antibody response intensity associated with taste or smell disorders.<h4>Methods</h4>We used data from SAPRIS, a study based on a consortium of five prospective cohorts gathering 279,478 participants in the French general population. In the analysis, we selected participants who were presumably infected by SARS-CoV-2 during the first epidemic wave.<h4>Results</h4>The analysis included 3,439 patients with a positive ELISA-Spike. Sex (OR = 1.28 [95% CI 1.05-1.58] for women), smoking (OR = 1.54 [95% CI 1.13-2.07]), consumption of more than 2 drinks of alcohol a day (OR = 1.37 [95% CI 1.06-1.76]) were associated w","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Apr","modification":"2025-04-26T06:04:25.102Z","creation":"2025-02-19T04:00:23.291Z"},"accession":"S-EPMC10103027","cross_references":{"pubmed":["37060075"],"doi":["10.1186/s12879-023-08162-7"]}}